Thiazolidinediones: metabolic actions in vitro C. FürnsinnW. Waldhäusl Review 05 July 2002 Pages: 1211 - 1223
Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study B. BalkauA. ForhanE. Eschwège Article 06 July 2002 Pages: 1224 - 1230
Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial M. TrentoP. PasseraM. Porta Article 11 July 2002 Pages: 1231 - 1239
A multi-centre, blinded international trial of the effect of A1 and A2 β-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes P. BealesR. ElliottF. Scott Article 19 July 2002 Pages: 1240 - 1246
The effect of birth weight on glucose tolerance in pigs at 3 and 12 months of age K. PooreA. Fowden Article 04 July 2002 Pages: 1247 - 1254
Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet P. YuM. WangL. Shira-Bock Article 08 August 2002 Pages: 1255 - 1262
Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice Q. WangP. Brubaker Article 26 April 2002 Pages: 1263 - 1273
Underestimation of D-glucose utilisation as judged from the conversion of D-[3-3H]glucose to 3HOH A. SenerM.-H. GiroixW. Malaisse Article 27 July 2002 Pages: 1274 - 1280
Improved stability, insulin-releasing activity and antidiabetic potential of two novel N-terminal analogues of gastric inhibitory polypeptide: N-acetyl-GIP and pGlu-GIP F. O'HarteV. GaultP. Flatt Article 16 July 2002 Pages: 1281 - 1291
Improved metabolic disorders of insulin receptor-deficient mice by transgenic overexpression of glucokinase in the liver M. JackerottA. BaudryR. Joshi Article 31 July 2002 Pages: 1292 - 1297
Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes A. AntonelliT. TuomiE. Ferrannini Article 24 July 2002 Pages: 1298 - 1306
The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice Z.-D. YangM. ChenJ.-L. Nadler Article 01 August 2002 Pages: 1307 - 1314
Total plasma homocysteine is associated with hypertension in Type I diabetic patients S. NeugebauerL. TarnowH.-H. Parving Article 08 August 2002 Pages: 1315 - 1324
Homocysteine enhances impairment of endothelium-dependent relaxation and guanosine cyclic monophosphate formation in aortae from diabetic rabbits N. ShuklaC. ThompsonJ. Jeremy Article 10 July 2002 Pages: 1325 - 1331
Involvement of neuropeptide Y in glucose sensing in the dorsal hypothalamus of streptozotocin diabetic rats – in vitro and in vivo studies of transmitter release M. GozaliJ. PaviaM. Morris Article 12 July 2002 Pages: 1332 - 1339
Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type I diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules M. PaniJ. Van AutreveK. Badenhoop Article 06 July 2002 Pages: 1340 - 1343
Rare variants identified in the HNF-4α β-cell-specific promoter and alternative exon 1 lack biological significance in maturity onset diabetes of the young and young onset Type II diabetes S. MitchellM. VaxillaireT. Frayling Article 19 July 2002 Pages: 1344 - 1348
Heat shock protein therapy fails to prevent diabetes in NOD mice M. A. Atkinson Observation 06 July 2002 Pages: 1350 - 1351
